EYE 3.33% 14.5¢ nova eye medical limited

Ann: Full Year Financial Results, page-200

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 17,203 Posts.
    lightbulb Created with Sketch. 4679
    New sales team getting to work fast, I’d say we should be seeing the full impact of the added sales force as early as the November update. Doesn’t seem like they need much time to settle in, they all have substantial experience selling medical products for major companies so this should be fairly easy work for them I assume!

    Assuming they will be EBITDA positive by then due to continued high sales growth (the trend seems to indicate they should be), the November update could also be a good opportunity for them to announce this to the market when they do the sales update, rather than simply providing the top line data as they usually do for the updates. A title like “Record Growth and First EBITDA Positive Quarter” could be quite exciting for the market.

    https://hotcopper.com.au/data/attachments/6423/6423610-39c8b9118d34635cf19800d72b1d5f8c.jpg

 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
(20min delay)
Last
14.5¢
Change
-0.005(3.33%)
Mkt cap ! $33.21M
Open High Low Value Volume
14.8¢ 15.0¢ 14.5¢ $34.06K 232.5K

Buyers (Bids)

No. Vol. Price($)
4 329492 14.5¢
 

Sellers (Offers)

Price($) Vol. No.
15.0¢ 244742 3
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
EYE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.